common.study.topics.clinical

Modulating Immunosuppression by Alveolar Efferocytosis

common.study.values.description

Modulation of Steroid Immunosuppression by Alveolar Efferocytosis

The long-term goals of this study are (a) to understand the biological underpinnings for the increased incidence of community-acquired pneumonia in patients with chronic obstructive pulmonary disease (COPD) who are treated with inhaled corticosteroids; and (b) to develop novel therapies to treated this problem using over-expression of micro-RNAs (miRNAs).

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Procedure - Bronchoscopy with bilateral bronchoalveolar lavages

Bronchoscopy with bilateral bronchoalveolar lavages

participant.views.study.view.additional

participant.views.study.view.scientific-title

Modulation of Steroid Immunosuppression by Alveolar Efferocytosis

common.study.values.clinical-trial-id

NCT03034642

participant.views.study.view.id

zbqm0b